NDC 0832-0044-89 - amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0832-0044
- Requested NDC
- 0832-0044-89
- Package NDCs from labels
- 0832-0044-09, 0832-0044-10, 0832-0044-89, 0832-0044-01
- Manufacturer
- Upsher-Smith Laboratories, LLC
- Effective date
- 2020-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| amlodipine besylate - Upsher-Smith Laboratories, LLC | Upsher-Smith Laboratories, LLC | 2020-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| amlodipine besylate | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| amlodipine | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| calcium phosphate, dibasic, dihydrate | INACTIVE INGREDIENT | O7TSZ97GEP | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| sodium starch glycolate type A potato | INACTIVE INGREDIENT | 5856J3G2A2 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | e9ecbadb-c548-6fe5-e053-2a95a90a7577 | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Bryant Ranch Prepack | d058e426-8786-4fd3-a771-992e4558c135 | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Ascend Laboratories, LLC | c1204fbe-d086-43cf-bbaa-efec9cd0487c | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Alembic Pharmaceuticals Inc. | 1346631f-e6db-4c5c-a6af-5aa7b80a011d | 2025-05-23 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Alembic Pharmaceuticals Limited | ecab983e-6ed8-4440-b7b4-7ac4bf39b26c | 2025-05-23 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | Strides Pharma Science Limited | 9b76e441-e6a5-4036-8276-b7788ade5c44 | 2025-04-10 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 921096ab-589a-4821-8d91-a6319f4a559a | 2025-04-09 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | dc2107cd-edfa-44a6-b139-edee6ccf47ce | 2025-04-08 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 00a037f6-b17f-4d21-9a9a-0e682f68d483 | 2025-04-02 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Camber Pharmaceuticals, Inc. | 99865c67-5475-4e60-98d5-a8fa850fe9ba | 2025-03-26 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 313fe7ba-2fbd-bb4d-e063-6294a90a3749 | 2025-03-26 | Warnings, Adverse reactions | 864V2Q084H |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 1dd12925-ede8-4ad5-9309-d8c79da1cebf | 2025-02-19 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | Proficient Rx LP | 6313edc5-d2d5-44a1-a06f-7f7829c870d2 | 2025-02-01 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Redpharm Drug | fc61eee9-ee15-9078-e053-6394a90a22f4 | 2025-01-23 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | DIRECT RX | b8b9a3cd-c4e7-dfeb-e053-2a95a90aa719 | 2025-01-17 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NCS HealthCare of KY, LLC dba Vangard Labs | 47f228e9-4a34-4d14-988d-b06af90124b9 | 2025-01-16 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 7c75fa72-9b0f-44bf-a745-dfa647ed1e78 | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| amlodipine,valsartan and hydrochlorothiazide | AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 1ea4f227-b97a-49f1-bbc3-1dede2c1866d | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE AND OLMESARTAN MEDOXOMIL | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Micro Labs Limited | 7fcf6a87-7b3e-4cef-8c47-c8a008cfea82 | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.